glp
Sport- und Kulturinstitutionen werden nicht nur über die Eintritte, sondern auch durch Steuergelder finanziert. Die EVP forderte, dass Auswärtige, welche keine …
My guest today is Zach Reitano, the co-founder and CEO of Ro, the country’s leading provider of GLP-1s. In four years, Ro has grown from a $250 million run rate…
イーライ・リリーが中国で経口肥満症治療薬として初の承認を取得し、市場の先取りに乗り出した。米国では次世代肥満症治療薬の生産に向け、35億ドル（約5兆ウォン）を投じて製造施設を建設する。ロイター通信によると、中国の医薬品規制当局は12日（現地時間）、リリーの経口グルカゴン様ペプチド1（GLP-1）系肥満症治療薬「オルフォ…
일라이 릴리가 중국에서 경구용 비만 치료제의 첫 허가를 받으며 시장 선점에 나섰다. 미국에서는 차세대 비만 치료제 생산을 위해 35억달러(약 5조원)를 투자해 제조시설을 짓는다. 로이터통신에 따르면 중국 의약품 규제당국은 12일(현지 시각) 릴리의 경구용 글루카곤 유사 펩타이드(GLP)…
Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes treatments to blockb…
In this episode of Science Quickly, Scientific American’s associate health editor Lauren Young joins host Kendra Pierre-Louis to talk about how the story of GLP…
Producătorii de medicamente de slăbit de succes, cum ar fi Ozempic și Zepbound, vor fi obligați să includă avertismente despre o afecțiune oculară rară care poa…
FDA 周一表示，GLP-1 药物生产商须在产品标签上增加一项可能导致突然失明的警示。被称为非动脉炎性前部缺血性视神经病变(nonarteritic anterior ischemic optic neuropathy，NAION)的眼部疾病会影响视神经——负责将信号从眼睛传输至大脑的神经。当流向视神经的血液减少或受阻…
The risk appears small and data is mixed, but FDA wants patients to be aware.
The data on which the FDA’s warning is based suggests a real but low risk of NAION for people taking GLP-1 medications.
